Clinical Trial

Pharmacokinetics and Safety Profiles of DA-1229_01 in Healthy Subjects at Fed State

Completed Phase 1
View on ClinicalTrials.gov →
Summary
This clinical study is to evaluate the safety/tolerability and pharmacokinetics of DA-1229\_01 at fed state.
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Completed 2026-04-08
Trial Details
NCT Number NCT07342062
Lead Sponsor Dong-A ST Co., Ltd.
Conditions Healthy
Enrollment 36 participants
Start Date 2026-01-06
Primary Completion 2026-02-14 (estimated)
Study Completion 2026-02-14 (estimated)
Updated on ClinicalTrials.gov 2026-04-07